588708-64-9

Upstream product

• 151-50-8 potassium cyanide 
• 93246-53-8 3-fluoro-4-(morpholinyl)aniline 
• 2689-39-6 3-fluoro-4-(4-morpholinyl)nitrobenzene 

Downstream Products

• 870843-45-1 3-fluoro-4-morpholin-4-yl-benzylamine 
• 351038-61-4 1-(3-fluoro-4-morpholinophenyl)butan-1-one 
• 588708-66-1 (S)-N-(3-fluoro-4-(morpholin-4-yl)benzoyl)-serine methyl ester 
• 588708-73-0 (R)-N-(3-fluoro-4-(morpholin-4-yl)benzoyl)-serine methyl ester 
• 588708-74-1 (R)-2-(3-fluoro-4-(morpholin-4-yl)phenyl)-4,5-dihydrooxazole-4-carboxylic acid methyl ester 
• 588708-67-2 (S)-2-(3-fluoro-4-(morpholin-4-yl)phenyl)-4,5-dihydrooxazole-4-carboxylic acid methyl ester 
• 588708-75-2 (S)-4-[4-(4-azidomethyl-4,5-dihydrooxazol-2-yl)-2-fluorophenyl]-morpholine 
• 588708-69-4 (R)-4-[4-(4-azidomethyl-4,5-dihydrooxazol-2-yl)-2-fluorophenyl]-morpholine 
• 588708-70-7 (S)-[2-(3-fluoro-4-(morpholin-4-yl)phenyl)-4,5-dihydrooxazol-4-yl]-methanol 
• 588708-68-3 (R)-[2-(3-fluoro-4-(morpholin-4-yl)phenyl)-4,5-dihydrooxazol-4-yl]-methanol 

Relevant academic research and scientific papers

Synthesis of dihydrooxazole analogues derived from linezolid

Starting from (S)-serine, the linezolid analogue 3 with dihydrooxazole partial structure was synthesized and pharmacologically investigated. With the help of MEP comparisons structural requirements for antibacterial activity were evaluated.